You are not logged in. Press here to login.


List volumes - List articles in this issue

Original report

Time-course and determinants of spasticity during the first six months following first-ever stroke

doi: 10.2340/16501977-0509

Open access


OBJECTIVE: To explore the occurrence of, and risk factors for, spasticity until 6 months after first-ever stroke.
METHODS: Forty-nine patients were examined at day 2–10, at 1 month, and at 6 months. The modified Ashworth Scale was used to assess resistance to passive movements. A comprehensive clinical examination was performed to identify other positive signs of upper motor neurone syndrome, in accordance with a broader definition of spasticity, and to evaluate whether spasticity was disabling. Neurological impairments were determined by use of the National Institutes of Health Stroke Scale and global disability by use of the modified Rankin Scale.
RESULTS: Spasticity was present in 2 patients (4%) at day 2–10, in 13 patients (27%) at 1 month, and in 11 patients (23%) at 6 months. Severe paresis of the arm at day 2–10 was associated with a higher risk for spasticity at 1 month (odds ratio = 10, 95% confidence interval 2.1–48.4). Dis­abling spasticity was present in one patient at 1 month and in 6 patients (13%) at 6 months.
CONCLUSION: Spasticity according to the modified Ashworth Scale usually occurs within 1 month and disabling spasticity later in a subgroup. Severe paresis of the arm is a risk factor for spasticity.


Erik Lundström, Anja Smits, Andreas Terént, Jörgen Borg


  1. Pandyan AD, Gregoric M, Barnes MP, Wood D, Van Wijck F, Burridge J, et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil 2005; 27: 2–6.
  2. Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology 1980; 30: 1303–1313.
  3. Ward AB. Spasticity treatment with botulinum toxins. J Neural Transm 2008; 115: 607–616.
  4. Francisco GE, Yablon SA, Schiess MC, Wiggs L, Cavalier S, Grissom S. Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia. Top Stroke Rehabil 2006; 13: 74–85.
  5. World Health Organization. International Classification of Functioning, Disability and Health. World Health Organization; 2001 [updated 2001; cited 2008 Nov 21]. Available from:
  6. Burridge JH, Wood DE, Hermens HJ, Voerman GE, Johnson GR, van Wijck F, et al. Theoretical and methodological considerations in the measurement of spasticity. Disabil Rehabil 2005; 27: 69–80.
  7. Hufschmidt A, Mauritz KH. Chronic transformation of muscle in spasticity: a peripheral contribution to increased tone. J Neurol Neurosurg Psychiatry 1985; 48: 676–685.
  8. Lundström E, Terent A, Borg J. Prevalence of disabling spasticity 1 year after first-ever stroke. Eur J Neurol 2008; 15: 533–539.
  9. Sommerfeld DK, Eek EU, Svensson AK, Holmqvist LW, von Arbin MH. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004; 35: 134–139.
  10. Watkins CL, Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK. Prevalence of spasticity post stroke. Clin Rehabil 2002; 16: 515–522.
  11. Welmer AK, von Arbin M, Widen Holmqvist L, Sommerfeld DK. Spasticity and its association with functioning and health-related quality of life 18 months after stroke. Cerebrovasc Dis 2006; 21: 247–253.
  12. Fellows SJ, Ross HF, Thilmann AF. The limitations of the tendon jerk as a marker of pathological stretch reflex activity in human spasticity. J Neurol Neurosurg Psychiatry 1993; 56: 531–537.
  13. Thilmann AF, Fellows SJ, Garms E. The mechanism of spastic muscle hypertonus. Variation in reflex gain over the time course of spasticity. Brain 1991; 114: 233–244.
  14. Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK, Watkins CL. Predicting spasticity after stroke in those surviving to 12 months. Clin Rehabil 2004; 18: 438–443.
  15. van Kuijk AA, Hendricks HT, Pasman JW, Kremer BH, Geurts AC. Are clinical characteristics associated with upper-extremity hypertonia in severe ischaemic supratentorial stroke? J Rehabil Med 2007; 39: 33–37.
  16. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980; 58: 113–130.
  17. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581–1587.
  18. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245–1251.
  19. Adams HP Jr., Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53: 126–131.
  20. Brott T, Adams H, Jr, Olinger C, Marler J, Barsan W, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864–870.
  21. Lyden P, Brott T, Tilley B, Welch K, Mascha E, Levine S, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994; 25: 2220–2226.
  22. Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL. Reliability of the Tone Assessment Scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil 1999; 80: 1013–1016.
  23. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206–207.
  24. Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol 2006; 5: 603–612.
  25. Burke D. Spasticity as an adaptation to pyramidal tract injury. Adv Neurol 1988; 47: 401–423.
  26. Sheean G. Neurophysiology of spasticity. In: Barnes MP, Johnson GR, editors. Upper Motor neurone syndrome and spasticity: clinical management and neurophysiology. Cambridge: Cambridge University Press; 2001, p. 12–78.
  27. Lin FM, Sabbahi M. Correlation of spasticity with hyperactive stretch reflexes and motor dysfunction in hemiplegia. Arch Phys Med Rehabil 1999; 80: 526–530.
  28. Katz RT, Rovai GP, Brait C, Rymer WZ. Objective quantification of spastic hypertonia: correlation with clinical findings. Arch Phys Med Rehabil 1992; 73: 339–347.
  29. O’Dwyer NJ, Ada L, Neilson PD. Spasticity and muscle contracture following stroke. Brain 1996; 119: 1737–1749.
  30. Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes MP, Rodgers H. A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil 1999; 13: 373–383.
  31. Malhotra S, Pandyan AD, Day CR, Jones PW, Hermens H. Spasticity, an impairment that is poorly defined and poorly measured. Clin Rehabil 2009; 23: 651–658.
  32. Barnes S, Gregson J, Leathley M, Smith T, Sharma A, Watkins C. Development and inter-rater reliability of an assessment tool for measuring muscle tone in people with hemiplegia after a stroke. Physiother Res Int 1999; 85: 405–409.

Related articles

There are no related articles.



Full text



There is no supplementary for this article.

Related articles

Click here to show related articles

Print information

Volume 42, Issue 4

DOI: 10.2340/16501977-0509

Pages: 296-301

View at PubMed